Jianjia Robot completes Series A financing
Jianjia Robot completed a Series A financing of tens of millions of yuan from BV Baidu Ventures to advance clinical trials of its Arthrobot joint-replacement system.
Evidence notes
- BV Baidu Ventures invested in the completed Series A round, with Haoyue Capital acting as exclusive financial adviser.
- Jianjia allocated the proceeds to clinical trials for Arthrobot, its first joint-replacement surgical robot.
- The company was founded in 2018 to develop robot-assisted planning and execution across joint-replacement workflows.
Company context
Jianjia Medical is a Chinese orthopaedic surgical-robotics company developing Arthrobot and multimodal navigation systems for joint, spine and trauma procedures.